Navigation Links
2020 vision of vaccines for malaria, TB and HIV/AIDS
Date:5/25/2011

parts alone. "The power of systems biology comes from its capacity to predict the behavior of an entire biological system," Aderem said. "From there, we can optimize vaccine candidates and predict whether a drug or vaccine candidate can work before it moves into large scale, very expensive clinical trials."

Systems biology can also be used to speed the often lengthy clinical trial experience. Aderem and Rappuoli estimate that in trials of new vaccines for malaria, TB and HIV/AIDS, only one hypothesis has been tested every eight years in the past three decades. "We cannot afford this approach if we want to have an impact on disease in a reasonable timeframe," Aderem said. "We can accelerate clinical development by performing more efficacy trials and by improving their design using systems biology approaches to test several hypotheses in parallel and having an adaptive design to expand the outcomes that prove most promising."

Aderem and Rappuoli also debunk one of the key criticisms of systems biology that it is overly reliant on computation. "Much of this comes from a misunderstanding on the role of computers in systems biology," Aderem explained. "Computers are not expected to come up with biological insights from the outset, but are meant to facilitate an integration of discovery science with hypothesis-driven science to yield a holistic description of a biological system."

While progress has been made over the past few years in the development of novel vaccines against the three most challenging infectious diseases in the world, Aderem and Rappuoli conclude that innovative design of clinical trials, testing several vaccines in parallel and getting early information using systems biology approaches will accelerate vaccine development and increase understanding of the human immune system.


'/>"/>

Contact: Jennifer Mortensen
jennifer.mortensen@seattlebiomed.org
206-256-7220
Seattle Biomedical Research Institute
Source:Eurekalert

Page: 1 2

Related biology news :

1. LIAI launches new division to look at novel approaches to heart disease and inflammation
2. Rong Li Lab probes mechanism of asymmetry in meiotic cell division
3. Gene therapy restores vision to mice with retinal degeneration
4. New cell division mechanism discovered
5. The bonsai effect: Wounded plants make jasmonates, inhibiting cell division, stunting growth
6. NYU biologist Bonneau named among 20 "visionary" scientists under 40 by Discover magazine
7. Proteins strangle cell during division
8. Billion-year revision of plant evolution timeline may stem from discovery of lignin in seaweed
9. TECNALIA uses artificial vision to improve recycling of electronic scrap metal
10. Scientists deconstruct cell division
11. Cells with double vision
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/14/2015)... DUBLIN , May 14, 2015 Research and ... addition of the "Fingerprint Sensors Market in Smart ... This report believes that 2014 was a watershed ... to Apple,s introduction of ,Apple Pay,. Apple gave fingerprint ... its mobile payment service. Fingerprint sensors are a must-have ...
(Date:5/11/2015)... 11, 2015  Synaptics Incorporated (NASDAQ: SYNA ... today announced the appointment of Wajid Ali ... Officer, reporting to Rick Bergman , President ... Financial Officer, Kathleen Bayless , who announced ... Mr. Ali brings extensive financial management expertise to ...
(Date:5/11/2015)... , May 11, 2015 Curemark LLC, ... the start of a new Phase III double blind, ... its novel formulation, CM-AT, on all children ages 3-8 ... its FDA Phase III double blinded clinical trial for ... low levels of the digestive enzyme chymotrypsin. This new ...
Breaking Biology News(10 mins):Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2
... Fla. For years, pilots flying into combat have jammed ... turns out that moths can do it, too. A ... hawkmoths use sonic pulses from their genitals to respond to ... to jam the echolocation ability of their predators. ...
... the VTT Technical Research Centre of Finland, lignocellulosic biomass can ... price of less than one euro per litre. A new ... half the energy of wood raw materials to the end-product. ... commercial-scale production plant in Europe. VTT has assessed the ...
... 2000, researchers at the UCLA Center for Sleep Research ... disorder characterized by uncontrollable periods of deep sleep, had ... their brains than healthy people. The study was the ... disorder. Subsequent work by this group ...
Cached Biology News:UF researcher shows hawkmoths use ultrasound to combat bats 2UF researcher shows hawkmoths use ultrasound to combat bats 3Gasification method turns forest residues to biofuel with less than a euro per liter 2UCLA researchers find new clue to cause of human narcolepsy 2
(Date:5/21/2015)... W. R. Grace & Co. ... Worms, Germany has received good manufacturing practice (GMP) ... International Pharmaceutical Excipient Council (IPEC) Foundation. ... SYLOID® FP brand of pharmaceutical grade excipient silica ... Curtis Bay, Maryland (USA) and Sorocaba, Brazil locations. ...
(Date:5/21/2015)...  CytRx Corporation (NASDAQ: CYTR ), a ... today announced positive updated results from its ongoing ... treatment of unresectable glioblastoma multiforme (GBM), a deadly ... is designed to investigate the preliminary efficacy and ... progressed following prior treatment with surgery, radiation and ...
(Date:5/21/2015)... DUBLIN , May 20, 2015 Research ... announced the addition of the "2015 Global ... to their offering. The primary goal ... of flow cytometry instruments and reagents. Key information ... drive the selection of flow cytometers, predominantly used ...
(Date:5/21/2015)... May 21, 2015 Veolia’s environmental ... exclusive North American distribution agreement with VWR to ... , With more than 160 years of experience, ... services for laboratory and production facilities, has cultivated ... and differentiated services to enable science. Endetec’s ...
Breaking Biology Technology:Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Global Survey on Flow Cytometry Adoption Trends 2015 2Veolia’s TECTA™ B16 Instrument for E. Coli Detection is Offered Exclusively Through VWR 2
... LLC.,today announced the addition of Mark Scherling to ... FCP as Program,Management Office and Siemens Practice Director., ... thought leadership,experience to FCP. Prior to joining FCP, ... at Catholic Healthcare West. Prior to that,responsibility, Mark ...
... Technologies GmbH,the leading developer of RAFT intervention therapeutics, ... trial of its lead RAFT modulator,TF002 in patients ... miltefosine, exerts its anti- inflammatory activity via RAFT,modulation. ... cells that,play a role in the complex physiological ...
... February 15, 2008 USC and Second Sight Medical Products ... announced today that they have completed enrollment of the first ... Argus II Retinal Prosthesis System. They also announced that enrollment ... Mexico. , We are pleased that Second Sight, along ...
Cached Biology Technology:FCP Welcomes Mark Scherling 2JADO Reports Clinical Proof of Concept With Raft Modulator in Atopic Dermatitis 2JADO Reports Clinical Proof of Concept With Raft Modulator in Atopic Dermatitis 3USC and second sight announce European clinical trial for Argus II retinal implant 2USC and second sight announce European clinical trial for Argus II retinal implant 3
... pre-validated SNP sequencing services ... within 93 genes including ... more than 80 tyrosine ... were developed and validated ...
... 384-Well Microarray plates are ideal for use as ... liquid handling applications (down to 5µl). These plates ... well design. Features 384 ... available 70µl well volume (cylindrical well), 55µl ...
Anti-Phospho-JKK/SEK1/MKK4 pAb Description: 100 g rabbit polyclonal antibody. Reacts with human/mouse/rat. Tested in WB. Research Focus: signal transduction Storage: -20C Shipping Tem...
...
Biology Products: